These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16765874)

  • 21. Appropriate use of digoxin in treating older nursing home patients with heart failure.
    Aronow WS
    J Am Med Dir Assoc; 2006 Nov; 7(9):604-6. PubMed ID: 17095428
    [No Abstract]   [Full Text] [Related]  

  • 22. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.
    Pradhan AA; Levine MA
    Can J Clin Pharmacol; 2002; 9(4):199-202. PubMed ID: 12584578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?
    Putnam W; Nicol K; Anderson D; Brownell B; Chiasson M; Burge FI; Flowerdew G; Cox J
    Can Fam Physician; 2004 Sep; 50():1244-50. PubMed ID: 15508374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of dabigatran utilization and prescribing patterns for atrial fibrillation in a physician group practice setting.
    Carley B; Griesbach S; Larson T; Krueger K
    Am J Cardiol; 2014 Feb; 113(4):650-4. PubMed ID: 24484861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation--changes 2000 to 2009.
    Charles J; Pan Y; Miller G
    Aust Fam Physician; 2010 Jul; 39(7):461. PubMed ID: 20628657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing anticoagulant therapy.
    Wheatley M; Cox JL; Nemis-White J
    Can Nurse; 2003 Jun; 99(6):16-9. PubMed ID: 12858669
    [No Abstract]   [Full Text] [Related]  

  • 29. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 30. Stroke and bleeding risk evaluation in atrial fibrillation: results of the European heart rhythm association survey.
    Larsen TB; Potpara T; Dagres N; Pison L; Estner H; Blomström-Lundqvist C;
    Europace; 2014 May; 16(5):698-702. PubMed ID: 24798958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation.
    Abdel-Latif AK; Peng X; Messinger-Rapport BJ
    J Am Med Dir Assoc; 2005; 6(2):128-31. PubMed ID: 15871888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based study of atrial fibrillation and stroke prevention.
    White S; Feely J; O'Neill D
    Ir Med J; 2004 Jan; 97(1):10-2. PubMed ID: 15055913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 37. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
    Man-Son-Hing M; Gage BF; Montgomery AA; Howitt A; Thomson R; Devereaux PJ; Protheroe J; Fahey T; Armstrong D; Laupacis A
    Med Decis Making; 2005; 25(5):548-59. PubMed ID: 16160210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demand for warfarin anticoagulation monitoring in Tayside, Scotland.
    Evans JM; Henderson LE; Goudie B; MacDonald TM; Davey PG
    Health Bull (Edinb); 1997 Mar; 55(2):88-93. PubMed ID: 9330496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Time to revise guidelines concerning anticoagulants in atrial fibrillation].
    Terént A
    Lakartidningen; 2002 Oct; 99(44):4375-7. PubMed ID: 12469584
    [No Abstract]   [Full Text] [Related]  

  • 40. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
    Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL;
    Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.